Bayer funds educational programs advancing knowledge of new therapies, treatment strategies, and quality of life in advanced prostate cancer.
Bayer funds educational initiatives advancing clinical knowledge and care in advanced prostate cancer, focusing on recent research, evidence gaps, and survivorship using innovative formats.
Bayer funds educational initiatives to enhance quality of life and patient-centered care in advanced prostate cancer, focusing on evidence-based approaches, cognitive outcomes, and survivorship.
Bayer funds educational projects to advance treatment strategies and clinical trial innovations in metastatic hormone-sensitive prostate cancer (mHSPC).
2026 Mars Shot Grant - Early Detection of Prostate Cancer supports researchers studying nuclear medicine for Stage I–II prostate cancer to improve patient management, potential survival, and quality of life.
Pfizer funds research and quality improvement projects to enhance care for elderly and complex HR+/HER2- metastatic breast cancer patients in Italy, focusing on real-world, patient-centered innovations.